BioPharma Credit PLC (OTCMKTS:BOPCF – Get Free Report) was the recipient of a large decline in short interest in the month of September. As of September 15th, there was short interest totaling 1,791 shares, a decline of 94.5% from the August 31st total of 32,491 shares. Based on an average daily trading volume, of 235,000 shares, the days-to-cover ratio is presently 0.0 days.
BioPharma Credit Stock Performance
BOPCF stock remained flat at $0.93 during midday trading on Friday. The firm has a fifty day simple moving average of $0.96 and a two-hundred day simple moving average of $0.95. BioPharma Credit has a 1-year low of $0.85 and a 1-year high of $1.02.
About BioPharma Credit
BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.
Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.
See Also
- Five stocks we like better than BioPharma Credit
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
- BlackBerry Shifts Gears With Coretura Deal
- NVIDIA’s Next AI Chip Ramp Could Open the Door to Another Major Stock Move
- Super Micro’s Vera Rubin Shipments Put Its AI Infrastructure Advantage to the Test
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
